ACADIA Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	177.7	319.59	188.66	114.85	147.44
Short-Term Investments	641.99	436.4	250.21	301.98	373.27
Cash & Short-Term Investments	819.69	755.99	438.87	416.82	520.71
Cash Growth	8.43%	72.26%	5.29%	-19.95%	-17.60%
Accounts Receivable	121.46	98.74	98.27	62.2	64.37
Other Receivables	26.77	5.96	4.08	0.89	0.98
Total Trade Receivables	148.23	104.7	102.35	63.08	65.34
Inventory	34.67	21.95	35.82	6.64	7.88
Other Current Assets	59.53	55.68	39.09	21.4	23.89
Total Current Assets	1,062	938.32	616.13	507.94	617.82
Net Property, Plant & Equipment	54.87	50.79	56.47	61.59	66.32
Other Intangible Assets	108.89	119.78	65.49	-	-
Other Long-Term Assets	338.32	78.87	10.87	18.28	15.98
Total Assets	1,564	1,188	748.96	587.81	700.12
Accounts Payable	10.9	16.19	17.54	12.75	6.88
Accrued Expenses	266.21	378.68	236.71	112.88	89.19
Total Current Liabilities	277.11	394.87	254.25	125.63	96.07
Long-Term Leases	40.55	42.04	47.8	52.7	56.13
Other Long-Term Liabilities	19.14	18.06	15.15	9.07	7.03
Total Long-Term Liabilities	59.69	60.09	62.95	61.77	63.16
Total Liabilities	336.81	454.96	317.2	187.4	159.23
Common Stock	0.02	0.02	0.02	0.02	0.02
Additional Paid-in Capital	3,039	2,937	2,863	2,771	2,695
Accumulated Other Comprehensive Income	1.45	0.29	0.02	-0.98	-0.19
Retained Earnings	-1,813	-2,204	-2,431	-2,370	-2,154
Shareholders' Equity	1,227	732.79	431.76	400.41	540.89
Total Liabilities & Equity	1,564	1,188	748.96	587.81	700.12
Total Debt	40.55	42.04	47.8	52.7	56.13
Net Cash (Debt)	779.13	713.96	391.07	364.13	464.58
Net Cash Growth	9.13%	82.57%	7.40%	-21.62%	-20.92%
Net Cash Per Share	4.58	4.29	2.39	2.25	2.90
Book Value	1,227	732.79	431.76	400.41	540.89
Book Value Per Share	7.22	4.40	2.64	2.48	3.37
Tangible Book Value	1,118	613.01	366.27	400.41	540.89
Tangible Book Value Per Share	6.58	3.68	2.24	2.48	3.37

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q